↓ Skip to main content

CD19: a biomarker for B cell development, lymphoma diagnosis and therapy

Overview of attention for article published in Experimental Hematology & Oncology, November 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#5 of 378)
  • High Attention Score compared to outputs of the same age (98th percentile)

Mentioned by

news
7 news outlets
blogs
3 blogs
policy
1 policy source
twitter
3 X users
patent
9 patents
wikipedia
9 Wikipedia pages

Citations

dimensions_citation
404 Dimensions

Readers on

mendeley
844 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy
Published in
Experimental Hematology & Oncology, November 2012
DOI 10.1186/2162-3619-1-36
Pubmed ID
Authors

Kemeng Wang, Guoqing Wei, Delong Liu

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 844 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
United Kingdom 2 <1%
Hungary 1 <1%
Ireland 1 <1%
Colombia 1 <1%
Germany 1 <1%
India 1 <1%
Unknown 835 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 160 19%
Student > Master 134 16%
Student > Ph. D. Student 111 13%
Researcher 84 10%
Student > Doctoral Student 42 5%
Other 83 10%
Unknown 230 27%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 196 23%
Agricultural and Biological Sciences 110 13%
Medicine and Dentistry 108 13%
Immunology and Microbiology 69 8%
Pharmacology, Toxicology and Pharmaceutical Science 21 2%
Other 98 12%
Unknown 242 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 82. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 February 2024.
All research outputs
#530,689
of 25,784,004 outputs
Outputs from Experimental Hematology & Oncology
#5
of 378 outputs
Outputs of similar age
#3,510
of 288,057 outputs
Outputs of similar age from Experimental Hematology & Oncology
#1
of 3 outputs
Altmetric has tracked 25,784,004 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 378 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 288,057 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them